These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 24676640)

  • 1. Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury.
    Burger D; Thibodeau JF; Holterman CE; Burns KD; Touyz RM; Kennedy CR
    J Am Soc Nephrol; 2014 Jul; 25(7):1401-7. PubMed ID: 24676640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podocyte-specific knockout of cyclooxygenase 2 exacerbates diabetic kidney disease.
    Wang L; Sha Y; Bai J; Eisner W; Sparks MA; Buckley AF; Spurney RF
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F430-F439. PubMed ID: 28490532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of urinary microparticles in normotensive patients with type 1 diabetes.
    Lytvyn Y; Xiao F; Kennedy CR; Perkins BA; Reich HN; Scholey JW; Cherney DZ; Burger D
    Diabetologia; 2017 Mar; 60(3):581-584. PubMed ID: 28004150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tell-tale signs of perturbed podocytes.
    Sharma K
    J Am Soc Nephrol; 2014 Jul; 25(7):1367-9. PubMed ID: 24676633
    [No Abstract]   [Full Text] [Related]  

  • 7. Schisandra chinensis fruit extract attenuates albuminuria and protects podocyte integrity in a mouse model of streptozotocin-induced diabetic nephropathy.
    Zhang M; Liu M; Xiong M; Gong J; Tan X
    J Ethnopharmacol; 2012 May; 141(1):111-8. PubMed ID: 22353431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex differences in progression of diabetic nephropathy in OVE26 type 1 diabetic mice.
    Wang W; Jiang S; Tang X; Cai L; Epstein PN; Cheng Y; Sun W; Xu Z; Tan Y
    Biochim Biophys Acta Mol Basis Dis; 2020 Jan; 1866(1):165589. PubMed ID: 31678163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitochondrial fission protects podocytes from albumin-induced cell damage in diabetic kidney disease.
    Tagaya M; Kume S; Yasuda-Yamahara M; Kuwagata S; Yamahara K; Takeda N; Tanaka Y; Chin-Kanasaki M; Nakae Y; Yokoi H; Mukoyama M; Ishihara N; Nomura M; Araki SI; Maegawa H
    Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166368. PubMed ID: 35202791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of acetyl CoA carboxylase β exacerbates podocyte injury in the kidney of streptozotocin-induced diabetic mice.
    Tanaka Y; Kume S; Maeda S; Osawa N; Takeda N; Chin-Kanasaki M; Isshiki K; Ugi S; Oshima I; Uzu T; Maegawa H; Araki SI
    Biochem Biophys Res Commun; 2018 Jan; 495(1):1115-1121. PubMed ID: 29175208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Podocyte-specific overexpression of the antioxidant metallothionein reduces diabetic nephropathy.
    Zheng S; Carlson EC; Yang L; Kralik PM; Huang Y; Epstein PN
    J Am Soc Nephrol; 2008 Nov; 19(11):2077-85. PubMed ID: 18632844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A; Cordasic N; Menendez-Castro C; Volkert G; Yabu JM; Kupraszewicz-Hutzler M; Rascher W; Hilgers KF
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1151-7. PubMed ID: 20826576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An adjustment in BMP4 function represents a treatment for diabetic nephropathy and podocyte injury.
    Fujita Y; Tominaga T; Abe H; Kangawa Y; Fukushima N; Ueda O; Jishage KI; Kishi S; Murakami T; Saga Y; Kanwar YS; Nagai K; Doi T
    Sci Rep; 2018 Aug; 8(1):13011. PubMed ID: 30158674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. eNOS deficiency predisposes podocytes to injury in diabetes.
    Yuen DA; Stead BE; Zhang Y; White KE; Kabir MG; Thai K; Advani SL; Connelly KA; Takano T; Zhu L; Cox AJ; Kelly DJ; Gibson IW; Takahashi T; Harris RC; Advani A
    J Am Soc Nephrol; 2012 Nov; 23(11):1810-23. PubMed ID: 22997257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
    Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
    Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.